InvestorsHub Logo
Followers 13
Posts 1812
Boards Moderated 0
Alias Born 03/29/2016

Re: biotech2010 post# 2858

Wednesday, 02/15/2017 5:42:33 PM

Wednesday, February 15, 2017 5:42:33 PM

Post# of 3833
I am just digging into this recently and CX trail remains to be seen. But GR-MD-02 isn't just about liver fibrosis.

GR-MD-02 in combined treatment with Merck's Keytruda, BMY's Yervoy as well as Roche's Anti-OX40 showed very good results with Keytruda and Anti-OX40 on melanoma skin cancer.

This front is generating interest from MRK, BMY, and ROG. Something to keep a close eye on this front.

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent GALT News